Physician profile
Jonathan Davis
NPI 1346745817
$3,852.16
in general payments reported to CMS, 2019-2025
17 companies · $550 in 2025
The $550 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $461 · 2021: $577 · 2022: $550 · 2023: $766 · 2024: $532 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $959.82 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $658.57 | 2022-2025 | Miebo, Xiidra, Infuse |
| Johnson & Johnson Vision Care, INC. | $627.89 | 2020-2024 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $273.80 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $224.52 | 2022-2024 | |
| Biotissue Holdings INC. | $148.64 | 2023 | |
| Oyster Point Pharma, INC. | $131.81 | 2023 | Tyrvaya |
| Glaukos Corporation | $126.54 | 2023 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2020 | |
| Harrow Eye, LLC | $122.11 | 2025 | Vevye |
| Abbvie INC. | $117.72 | 2023 | Alphagan P, Lumigan |
| Coopervision INC. | $116.05 | 2019 | |
| Aerie Pharmaceuticals, INC. | $100.53 | 2020 | |
| Optos, INC. | $61.70 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $23.48 | 2025 | Xdemvy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $14.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.